These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12066772)

  • 1. Turnover of plasma cholesterol in man.
    Goodman DS; Noble RP
    J Clin Invest; 1968 Feb; 47(2):231-41. PubMed ID: 12066772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-pool model of the long-term turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Lipid Res; 1973 Mar; 14(2):178-88. PubMed ID: 4698266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans.
    Smith FR; Dell RB; Noble RP; Goodman DS
    J Clin Invest; 1976 Jan; 57(1):137-48. PubMed ID: 1245596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and turnover of cholesterol in humans.
    Nestel PJ; Whyte HM; Goodman DS
    J Clin Invest; 1969 Jun; 48(6):982-91. PubMed ID: 5771198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholestyramine on tissue pools of cholesterol a preliminary report.
    Kudchodkar BJ; Sodhi HS; Horlick L; Nazir DJ
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):393-6. PubMed ID: 1121487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
    Redinger RN; Passi RB
    Can J Physiol Pharmacol; 1979 Mar; 57(3):235-41. PubMed ID: 109175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of cholesterol turnover in hypercholesterolemic (type II) patients.
    Bhat tacharyya AK; Connor WE; Spector AA
    J Lab Clin Med; 1976 Aug; 88(2):202-14. PubMed ID: 182888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
    Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC
    Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia.
    Angelin B; Einarsson K; Hellström K; Leijd B
    J Lipid Res; 1978 Nov; 19(8):1017-24. PubMed ID: 731123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the parameters of whole body cholesterol metabolism in humans.
    Goodman DS; Smith FR; Seplowitz AH; Ramakrishnan R; Dell RB
    J Lipid Res; 1980 Aug; 21(6):699-713. PubMed ID: 7419983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.
    Goldberg IJ; Holleran S; Ramakrishnan R; Adams M; Palmer RH; Dell RB; Goodman DS
    J Clin Invest; 1990 Sep; 86(3):801-8. PubMed ID: 2394831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cholesterol reduction with cholestyramine on renal function.
    Kshirsagar AV; Shoham DA; Bang H; Hogan SL; Simpson RJ; Colindres RE
    Am J Kidney Dis; 2005 Nov; 46(5):812-9. PubMed ID: 16253720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholestyramine on vitamin E levels in patients treated with statins.
    Kersting F; Selenka A; Walch S
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1476-9. PubMed ID: 11185669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of fecal bile acid excretion in male golden Syrian hamsters fed a cereal-based diet with and without added cholesterol.
    Turley SD; Spady DK; Dietschy JM
    Hepatology; 1997 Apr; 25(4):797-803. PubMed ID: 9096579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD; Dietschy JM; Turley SD
    Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.